Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

The issuer is solely responsible for the content of this announcement.

RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...

“My son’s lips, at this point, started to turn blue. He also had a febrile seizure, which is why his body was stiff and ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

The CDC says New Mexico is one of more than 20 states in the “very high” level of influenza activity, the highest category.

Just over a month into the new year, influenza season is hitting hard in the Southland, and the flu isn't the only virus ...

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

The “Quaddemic” includes Influenza, COVID, RSV and Adenovirus. All four viruses are hitting the community harder than ever.